Related Experiment Video
Updated: Jul 6, 2026

Fluorescence-mediated Tomography for the Detection and Quantification of Macrophage-related Murine Intestinal Inflammation
Published on: December 15, 2017
[The application of Montreal classification in inflammatory bowel disease]
Chuan-Hua Yang1, Xiang Chen, Jun Dai
1Renji Hospital, Shanghai Institute of Digestive Disease, Shanghai Jiaotong University Medical College, Shanghai 200001, China.
Objective:
To investigate the clinical features of Crohn's disease (CD) and ulcerative colitis (UC) according to the Montreal classification.
Methods:
The clinical data of 110 cases of CD or UC were reviewed. The age at diagnosis, location and clinical behavior were assessed with the Montreal criteria.
Results:
CD patients diagnosed at an age younger than 16 years were rare (3.6%), the majority of the CD patients was diagnosed at 17 - 40 years old (65.5%). Although ileocolon lesions were most common in the patients diagnosed at 17 - 40 years old (37.3%), yet ileum lesions were a little more than those of other parts of digestive tract in the patients diagnosed after 40 years old (14.5%), the difference was not significant (P = 0.054). Stricture frequently occurred (50.4%), especially when the lesions were located at ileum or ileocolon. Perforation rarely happened (5.3%). There was no significant difference between different location groups for clinical behaviors (P = 0.096). The incidence of stricture or perforation was almost same among different age groups (P = 0.984). UC patients mostly presented with mild or moderate symptoms even in the group with extensive lesion. UC patients with severe symptoms were rare (6.8%). There was no significant difference in severity between the groups with different extent of lesion (P = 0.056).
Conclusions:
The majority of CD patients was diagnosed at 17 - 40 years old. Stricture is much more than perforation, penetrating, occurring mostly at ileum. UC patients mostly present mild or moderate symptoms, no matter how extensive the lesion is. The extent of the lesion detected with colposcopic examination is not correlated to the severity of clinical manifestations.
Related Concept Videos
Inflammatory Bowel Disease I: Introduction
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by transmural...
Inflammatory Bowel Disease II: Ulcerative Colitis
Inflammatory Bowel Disease III: Crohn's Disease
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the colonic...

